# Banka BioLoo (NSE: BANKA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BANKA · Pivot · prices to 22 Oct 2026

Banka BioLoo (NSE: BANKA) closed at ₹66.74 on 22 Oct 2026, up 0.21% on the day. With a market capitalisation of ₹73 Cr, it ranks 2839th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Capital Goods sector; its industry is Pollution & Treatment Controls.

Its return on equity was 0.9% in FY26. Over the past year the share price has fallen 20.8%. Its 52-week range is ₹41.00 (30 Mar 2026) to ₹96.58 (3 Jul 2026); the last close is 30.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹18 Cr (+19.1% year on year) and net profit ₹2 Cr, on a consolidated basis. Promoters held 52.02% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹66.74 |
| Market cap | ₹73 Cr |
| ROE | 0.9% (FY26) |
| ROCE | 6.4% (FY26) |
| Debt to equity | 0.99 |
| 52-week high | ₹96.58 (3 Jul 2026) |
| 52-week low | ₹41.00 (30 Mar 2026) |
| 1-year return | −20.8% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹18 Cr | +19.1% | ₹2 Cr | — | ₹1.45 |
| Q3 FY26 | ₹15 Cr | +8.7% | −₹0 Cr | — | −₹0.14 |
| Q2 FY26 | ₹13 Cr | +4.8% | −₹1 Cr | — | −₹1.00 |
| Q1 FY26 | ₹11 Cr | −13.6% | −₹0 Cr | −103.6% | −₹0.01 |
| Q4 FY25 | ₹15 Cr | −9.0% | −₹2 Cr | — | −₹1.50 |
| Q3 FY25 | ₹14 Cr | +0.6% | −₹1 Cr | −311.6% | −₹1.34 |
| Q2 FY25 | ₹12 Cr | +8.4% | −₹6 Cr | −606.6% | −₹5.65 |
| Q1 FY25 | ₹13 Cr | +55.7% | ₹0 Cr | — | ₹0.27 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹54 Cr | −₹9 Cr |
| FY24 | ₹50 Cr | −₹1 Cr |
| FY23 | ₹42 Cr | ₹3 Cr |
| FY22 | ₹39 Cr | ₹3 Cr |
| FY21 | ₹30 Cr | ₹2 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 52.02%
- Non-institutions: 47.98%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [AMPVOLTS](https://app.pivotnow.in/stock/AMPVOLTS) | — | ₹77 Cr | — | — |
| [NRB Industrial Bearings](https://app.pivotnow.in/stock/NIBL) | ₹30.70 | ₹74 Cr | 4.4 | — |
| [Yuvraaj Hygiene](https://app.pivotnow.in/stock/YUVRAAJHPL) | — | ₹74 Cr | — | — |
| [Siyaram Recycli](https://app.pivotnow.in/stock/SIYARAM) | — | ₹74 Cr | — | — |
| [Edvenswa Ent.](https://app.pivotnow.in/stock/EDVENSWA) | — | ₹73 Cr | — | — |
| [Semac Construction](https://app.pivotnow.in/stock/SEMAC) | ₹226.43 | ₹71 Cr | 9.7 | — |

## Questions and answers

### What is the share price of Banka BioLoo today?

Banka BioLoo (NSE: BANKA) last closed at ₹66.74 on 22 Oct 2026. Its 52-week high is ₹96.58 and its 52-week low is ₹41.00.

### What is the market cap of Banka BioLoo?

Banka BioLoo's market capitalisation is ₹73 Cr (₹73 Cr) at the 22 Oct 2026 close, ranking 2839th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Banka BioLoo?

Return on equity was 0.9% in FY26 and return on capital employed was 6.4% in FY26 (consolidated figures).

### Is Banka BioLoo a debt-free company?

No. Banka BioLoo's debt-to-equity ratio was 0.99 in FY26, with total debt of ₹13 Cr.

### What were Banka BioLoo's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Banka BioLoo reported revenue of ₹18 Cr, +19.1% year on year, and net profit of ₹2 Cr.

### How has Banka BioLoo stock performed over the last year?

Banka BioLoo's share price has fallen 20.8% over the past year, −25.0% over three months and −13.9% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Banka BioLoo?

As of 30 Jun 2026: promoters 52.02%, non-institutions 47.98%.

### Who are Banka BioLoo's competitors?

The listed Capital Goods companies closest to Banka BioLoo by market cap are AMPVOLTS, NRB Industrial Bearings, Yuvraaj Hygiene, Siyaram Recycli, Edvenswa Ent. and Semac Construction.

### Is Banka BioLoo a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Banka BioLoo's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BANKA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.